These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28180075)

  • 21. Amyloid cascade and tau pathology cerebrospinal fluid markers in mild cognitive impairment with regards to Alzheimer's disease cerebral metabolic signature.
    Alexopoulos P; Guo LH; Jiang M; Bujo H; Grimmer T; Förster S; Drzezga A; Kurz A; Perneczky R
    J Alzheimers Dis; 2013; 36(2):401-8. PubMed ID: 23609762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
    Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
    J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
    Espinosa A; Alegret M; Pesini P; Valero S; Lafuente A; Buendía M; San José I; Ibarria M; Tejero MA; Giménez J; Ruiz S; Hernández I; Pujadas F; Martínez-Lage P; Munuera J; Arbizu J; Tárraga L; Hendrix SB; Ruiz A; Becker JT; Landau SM; Sotolongo-Grau O; Sarasa M; Boada M; ;
    J Alzheimers Dis; 2017; 57(2):447-459. PubMed ID: 28269787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-Linear Association between Cerebral Amyloid Deposition and White Matter Microstructure in Cognitively Healthy Older Adults.
    Wolf D; Fischer FU; Scheurich A; Fellgiebel A;
    J Alzheimers Dis; 2015; 47(1):117-27. PubMed ID: 26402760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Posterior atrophy predicts time to dementia in patients with amyloid-positive mild cognitive impairment.
    Pyun JM; Park YH; Kim HR; Suh J; Kang MJ; Kim BJ; Youn YC; Jang JW; Kim S;
    Alzheimers Res Ther; 2017 Dec; 9(1):99. PubMed ID: 29246250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. White Matter Degradation is Associated with Reduced Financial Capacity in Mild Cognitive Impairment and Alzheimer's Disease.
    Gerstenecker A; Hoagey DA; Marson DC; Kennedy KM
    J Alzheimers Dis; 2017; 60(2):537-547. PubMed ID: 28826185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer disease.
    Dodge HH; Zhu J; Harvey D; Saito N; Silbert LC; Kaye JA; Koeppe RA; Albin RL;
    Alzheimers Dement; 2014 Nov; 10(6):690-703. PubMed ID: 25022534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Resilience on the Association Between Amyloid-β and Longitudinal Cognitive Decline in Cognitively Healthy Older Adults.
    Wolf D; Fischer FU; Fellgiebel A;
    J Alzheimers Dis; 2019; 70(2):361-370. PubMed ID: 31256140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hippocampal Mean Diffusivity for the Diagnosis of Dementia and Mild Cognitive Impairment in Primary Care.
    Brueggen K; Dyrba M; Kilimann I; Henf J; Hoffmann W; Thyrian JR; Teipel S
    Curr Alzheimer Res; 2018; 15(11):1005-1012. PubMed ID: 29895247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal volumetric MRI change and rate of cognitive decline.
    Mungas D; Harvey D; Reed BR; Jagust WJ; DeCarli C; Beckett L; Mack WJ; Kramer JH; Weiner MW; Schuff N; Chui HC
    Neurology; 2005 Aug; 65(4):565-71. PubMed ID: 16116117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of Alzheimer's Dementia in Patients with Amnestic Mild Cognitive Impairment in Clinical Routine: Incremental Value of Biomarkers of Neurodegeneration and Brain Amyloidosis Added Stepwise to Cognitive Status.
    Lange C; Suppa P; Pietrzyk U; Makowski MR; Spies L; Peters O; Buchert R;
    J Alzheimers Dis; 2018; 61(1):373-388. PubMed ID: 29154285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral Amyloid Angiopathy Is Associated With Executive Dysfunction and Mild Cognitive Impairment.
    Case NF; Charlton A; Zwiers A; Batool S; McCreary CR; Hogan DB; Ismail Z; Zerna C; Coutts SB; Frayne R; Goodyear B; Haffenden A; Smith EE
    Stroke; 2016 Aug; 47(8):2010-6. PubMed ID: 27338926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deep microbleeds and periventricular white matter disintegrity are independent predictors of attention/executive dysfunction in non-dementia patients with small vessel disease.
    Cao WW; Wang Y; Dong Q; Chen X; Li YS; Zhou Y; Gao L; Deng Y; Xu Q
    Int Psychogeriatr; 2017 May; 29(5):793-803. PubMed ID: 27938433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease trajectories in elders with suspected non-Alzheimer's pathophysiology and its comparison with Alzheimer's disease pathophysiology: a longitudinal study.
    Li JQ; Song JH; Suckling J; Wang YJ; Zuo CT; Zhang C; Gao J; Song YQ; Xie AM; Tan L; Yu JT
    Res Sq; 2023 Mar; ():. PubMed ID: 37034751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A robust brain signature region approach for episodic memory performance in older adults.
    Fletcher E; Gavett B; Crane P; Soldan A; Hohman T; Farias S; Widaman K; Groot C; Renteria MA; Zahodne L; DeCarli C; Mungas D;
    Brain; 2021 May; 144(4):1089-1102. PubMed ID: 33895818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment.
    Gibbons LE; Carle AC; Mackin RS; Harvey D; Mukherjee S; Insel P; Curtis SM; Mungas D; Crane PK;
    Brain Imaging Behav; 2012 Dec; 6(4):517-27. PubMed ID: 22644789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retained executive abilities in mild cognitive impairment are associated with increased white matter network connectivity.
    Farrar DC; Mian AZ; Budson AE; Moss MB; Koo BB; Killiany RJ;
    Eur Radiol; 2018 Jan; 28(1):340-347. PubMed ID: 28695358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Florbetapir positron emission tomography and cerebrospinal fluid biomarkers.
    Hake A; Trzepacz PT; Wang S; Yu P; Case M; Hochstetler H; Witte MM; Degenhardt EK; Dean RA;
    Alzheimers Dement; 2015 Aug; 11(8):986-93. PubMed ID: 25916563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.